|
US570561A
(en)
|
|
1896-11-03 |
|
S peters co |
|
US2808035A
(en)
|
1953-04-23 |
1957-10-01 |
Riley Stoker Corp |
Burning wet materials
|
|
JPS5623587A
(en)
|
1979-08-03 |
1981-03-05 |
Mitsuwa Seiki Co Ltd |
Vane type compressor
|
|
JPS58110600A
(ja)
|
1981-12-25 |
1983-07-01 |
Kyowa Hakko Kogyo Co Ltd |
ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
|
|
WO1985003934A1
(fr)
|
1984-03-06 |
1985-09-12 |
Takeda Chemical Industries, Ltd. |
Proteine modifiee chimiquement et son procede de preparation
|
|
JPS60221091A
(ja)
|
1983-12-21 |
1985-11-05 |
Kyowa Hakko Kogyo Co Ltd |
新規プロモ−タ−
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
JP2564268B2
(ja)
|
1985-08-28 |
1996-12-18 |
協和醗酵工業株式会社 |
融合抗原ポリペプチド
|
|
ZA872705B
(en)
|
1986-04-22 |
1987-10-05 |
Immunex Corporation |
Human g-csf protein expression
|
|
JP2958019B2
(ja)
|
1988-05-06 |
1999-10-06 |
住友製薬株式会社 |
ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法
|
|
JP2928287B2
(ja)
|
1988-09-29 |
1999-08-03 |
協和醗酵工業株式会社 |
新規ポリペプチド
|
|
JPH02257891A
(ja)
|
1989-03-31 |
1990-10-18 |
Kyowa Hakko Kogyo Co Ltd |
組換え動物細胞による蛋白質の製造
|
|
JPH0322979A
(ja)
|
1989-06-19 |
1991-01-31 |
Kyowa Hakko Kogyo Co Ltd |
新規プラスミノーゲン活性化因子
|
|
JP3131322B2
(ja)
|
1991-12-17 |
2001-01-31 |
協和醗酵工業株式会社 |
新規α２→３シアリルトランスフェラーゼ
|
|
US6042828A
(en)
|
1992-09-07 |
2000-03-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Humanized antibodies to ganglioside GM2
|
|
SG49117A1
(en)
|
1993-03-29 |
1998-05-18 |
Kyowa Hakko Kogyo Kk |
Alfa -1, 3-fucosyltransferase
|
|
US5705614A
(en)
|
1993-04-09 |
1998-01-06 |
Chiron Corporation |
Methods of producing antigen forks
|
|
AU6267896A
(en)
|
1995-06-07 |
1996-12-30 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth oftumors
|
|
CN1241944C
(zh)
|
1995-09-11 |
2006-02-15 |
协和发酵工业株式会社 |
抗人白介素－5受体α链的抗体
|
|
US6001358A
(en)
|
1995-11-07 |
1999-12-14 |
Idec Pharmaceuticals Corporation |
Humanized antibodies to human gp39, compositions containing thereof
|
|
JP4213224B2
(ja)
|
1997-05-02 |
2009-01-21 |
ジェネンテック，インコーポレーテッド |
ヘテロマルチマー及び共通成分を有する多重特異性抗体の製造方法
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
HU230769B1
(hu)
|
1999-01-15 |
2018-03-28 |
Genentech Inc. |
Módosított effektor-funkciójú polipeptid-változatok
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
EP1176195B1
(en)
|
1999-04-09 |
2013-05-22 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
CN101289511A
(zh)
|
2000-04-11 |
2008-10-22 |
杰南技术公司 |
多价抗体及其应用
|
|
EP2990420B1
(en)
*
|
2000-05-26 |
2016-12-21 |
Immunex Corporation |
Use of interleukin-4 receptor antibodies and compositions thereof
|
|
KR100919593B1
(ko)
|
2000-06-29 |
2009-09-29 |
아보트 러보러터리즈 |
이중 특이성 항체 및 이의 제조 방법 및 이를 포함하는 조성물
|
|
ES2639222T5
(es)
|
2000-10-06 |
2023-11-24 |
Kyowa Kirin Co Ltd |
Células que producen unas composiciones de anticuerpo
|
|
WO2003033538A1
(en)
|
2001-10-15 |
2003-04-24 |
Kirin Beer Kabushiki Kaisha |
Anti-hla-dr antibody
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
US20080241884A1
(en)
|
2003-10-08 |
2008-10-02 |
Kenya Shitara |
Fused Protein Composition
|
|
US8911726B2
(en)
|
2004-09-22 |
2014-12-16 |
Kyowa Hakko Kirin Co., Ltd |
Stabilized human Igg4 antibodies
|
|
US7923538B2
(en)
|
2005-07-22 |
2011-04-12 |
Kyowa Hakko Kirin Co., Ltd |
Recombinant antibody composition
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
WO2009131239A1
(ja)
|
2008-04-25 |
2009-10-29 |
Kyowa Hakko Kirin Co Ltd |
安定な多価抗体
|
|
DK2356270T3
(da)
*
|
2008-11-07 |
2016-12-12 |
Fabrus Llc |
Kombinatoriske antistofbiblioteker og anvendelser deraf
|
|
KR20120024763A
(ko)
*
|
2009-05-15 |
2012-03-14 |
추가이 세이야쿠 가부시키가이샤 |
항ａｘｌ 항체
|
|
BRPI1010759B1
(pt)
|
2009-06-11 |
2019-07-16 |
Inter-University Research Institute Corporation Research Organization Of Information And Systems |
Método para produzir uma proteína de interesse ou para obter uma suspensão de células de mamíferos capaz de produzir uma proteína de interesse, bem como vetor de expressão de proteína
|
|
WO2011116387A1
(en)
|
2010-03-19 |
2011-09-22 |
Tetragenetics, Inc. |
Production of aglycosylated monoclonal antibodies in ciliates
|
|
AR084020A1
(es)
|
2010-11-30 |
2013-04-17 |
Genentech Inc |
Anticuerpos para el receptor de la barrera hematoencefalica de baja afinidad y sus usos
|
|
CN105968209B
(zh)
|
2011-04-19 |
2021-08-03 |
美国政府(由卫生和人类服务部的部长所代表) |
对磷脂酰肌醇蛋白聚糖3特异的人单克隆抗体及其用途
|
|
US9598496B2
(en)
|
2011-05-09 |
2017-03-21 |
Perseus Proteomics Inc. |
Antibody capable of specifically recognizing transferrin receptor
|
|
US8691231B2
(en)
|
2011-06-03 |
2014-04-08 |
Merrimack Pharmaceuticals, Inc. |
Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
|
|
LT2794905T
(lt)
|
2011-12-20 |
2020-07-10 |
Medimmune, Llc |
Modifikuoti polipeptidai, skirti bispecifinių antikūnų karkasams
|
|
MX361875B
(es)
|
2012-03-14 |
2018-12-18 |
Regeneron Pharma |
Moléculas de unión de antígeno multiespecifícas y usos de las mismas.
|
|
AU2013266611B2
(en)
|
2012-05-21 |
2016-08-11 |
Genentech, Inc. |
Methods for improving safety of blood-brain barrier transport
|
|
WO2014189973A2
(en)
|
2013-05-20 |
2014-11-27 |
Genentech, Inc. |
Anti-transferrin receptor antibodies and methods of use
|
|
CN104211814A
(zh)
|
2013-05-29 |
2014-12-17 |
三星电子株式会社 |
用于消耗靶膜蛋白的组合物
|
|
TWI853985B
(zh)
*
|
2013-12-04 |
2024-09-01 |
日商中外製藥股份有限公司 |
因應化合物濃度使抗原結合能力變化的抗原結合分子及其資料庫
|
|
SG11201608253XA
(en)
*
|
2014-04-04 |
2016-10-28 |
Kyowa Hakko Kirin Co Ltd |
Anti-death receptor 3 (dr3) antagonistic antibodies with reduced agonistic activity
|
|
EP3221362B1
(en)
*
|
2014-11-19 |
2019-07-24 |
F.Hoffmann-La Roche Ag |
Anti-transferrin receptor antibodies and methods of use
|
|
EP3221361B1
(en)
*
|
2014-11-19 |
2021-04-21 |
Genentech, Inc. |
Anti-transferrin receptor / anti-bace1 multispecific antibodies and methods of use
|
|
SG11201705632UA
(en)
*
|
2015-01-08 |
2017-08-30 |
Kyowa Hakko Kirin Co Ltd |
Bispecific antibody binding to trailr2 and psma
|
|
MX391086B
(es)
*
|
2015-06-24 |
2025-03-21 |
Hoffmann La Roche |
Anticuerpos anti-receptor de transferrina con afinidad diseñada.
|
|
CA2992262A1
(en)
*
|
2015-07-15 |
2017-01-19 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody which specifically binds to human crth2
|
|
KR20190005944A
(ko)
|
2016-05-09 |
2019-01-16 |
애넥슨, 인코포레이티드 |
척수성 근위축 치료용 조성물 및 방법
|
|
KR102156626B1
(ko)
|
2018-07-16 |
2020-09-17 |
주식회사 셀바스에이아이 |
운동 처방 정보를 제공하는 서버 및 컴퓨터 프로그램
|